Table 4 Haplotype frequencies in PD cases and controls
From: Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease
| Haplotypes1 | Swedish material | Polish material | ||
|---|---|---|---|---|
| Parkinson | Control | Parkinson | Control | |
| NFE2L2 tag SNPs 2-6 | ||||
| AGGAG | 26.2% | 30.6% | 33.9% | 28.2% |
| AAGAG | 22.2% | 22.0% | 20.5% | 20.5% |
| GAAAA | 21.5% | 26.7% | 18.4% | 27.7% |
| GAGGG | 10.9% | 5.5% | 9.7% | 9.6% |
| GAGAA | 10.2% | 9.1% | 9.9% | 7.1% |
| GAAAG | 5.4% | 1.7% | 1.4% | 2.5% |
| NFE2L2 promoter P1-P3 | ||||
| AGC | 47.5% | 47.0% | 40.8% | 48.1% |
| GGC | 27.2% | 31.2% | 33.8% | 27.0% |
| AAC | 12.6% | 13.8% | 12.3% | 12.3% |
| AGA | 12.6% | 7.9% | 13.1% | 12.6% |
| KEAP1 tag SNPs 1-3 | ||||
| TGC | 55.8% | 52.7% | --- | --- |
| TGG | 26.1% | 27.7% | --- | --- |
| CGG | 11.0% | 12.0% | --- | --- |
| TTC | 6.7% | 7.4% | --- | --- |
